Probiodrug to Present an Update on QC Inhibition as Potential New Treatment for Alzheimer’s Disease at the International Conference on Alzheimer Disease – ICAD – 2009 in Vienna, Austria, July 11-16

Probiodrug Announces Validity of European Patent Covering Use of DP4 inhibitors for the Treatment of Anxiety
Probiodrug Closes Series B Financing Round exceeding EUR 36 Million (US$54 Million)